The Global Health Research Network

Optimizing Clinical Research to Bring New Therapies to Market Faster

TriNetX was founded on the idea that incorporating real-world data results in better clinical trial design, improves the site selection and patient recruitment process and generates real-world evidence (RWE) to advance the collective understanding of human health. TriNetX collaborates with the majority of industry leaders, including 13 of the top 15 pharmaceutical companies, and is powered by an impressive network of 170 healthcare organizations across 30 countries.

As a result of its reach and rapidly expanding network, TriNetX has become the market leader in protocol design, feasibility and site selection. Researchers have leveraged the TriNetX network to analyze over 34,000 protocols, presented over 7,800 clinical trial opportunities to its healthcare members, and reduced site identification time in clinical trials by 50%.

Who We Work With

Clinical trials are becoming ever more complex, and anything we can do to reduce the time and cost of a trial means therapies can be evaluated more rapidly and reach people faster. Working with companies like TriNetX is an important way to do that, by bringing both technology and knowledge to Sanofi’s work.

Lionel Bascles, Global Head of Clinical Sciences and Operations, Sanofi

Collaborate with Leading Healthcare Organizations

We Take Security Seriously

All sites are under either business associate agreements (BAA) or appropriate international legal frameworks. The TriNetX platform has been expertly reviewed to ensure that the governance rules and policies meet or exceed the HIPAA standard. TriNetX’s dedicated security and compliance team oversees data governance to prevent exposure of PHI/PI. Patients are only re-identifiable by the healthcare organization.